What can't weight-loss meds do? Eli Lilly is going to test Zepbound as a treatment for addiction
Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster ...
Becker's Hospital Review16h
Eli Lilly to test weight loss drugs as addiction treatments
Eli Lilly will launch studies to investigate whether its weight loss medications can help control addictive behaviors such as smoking and alcohol and drug abuse, CEO Dave Ricks revealed in a Dec. 10 ...
NBC Los Angeles19h
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly’s direct-to-consumer website, and aims to streamline ...
Medpage Today on MSN5d
Should Pharmaceutical Companies Sell Weight-Loss Drugs Directly to Consumers?
Conversely, Eduardo Grunvald, MD, medical director of the weight management program at UC San Diego Health, sees less of an issue as long as there is a legitimate prescriber. Some of his patients have ...
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
By Sneha S K (Reuters) -Telehealth company Ro said on Wednesday it will offer single-dose vials of Eli Lilly's weight-loss ...
The Motley Fool5d
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Eli Lilly and Novo Nordisk dominate the market for weight loss drugs, and demand for their products has surpassed supply in recent times. Lilly’s weight loss portfolio has already delivered ...
Nasdaq5d
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
The same goes for biotech Viking's promising candidate. So, the 2025 weight loss market will be one dominated by Novo Nordisk and Eli Lilly. Right now, Novo Nordisk holds the top spot -- it was ...
Yahoo Finance6d
The Weight Loss Drug Race Heats Up: Eli Lilly's Zepbound Outperforms Wegovy in Weight Loss Trials
Eli Lilly (NYSE:LLY) has been making headlines recently with its weight-loss drug Zepbound (tirzepatide). Eli Lilly's weight-loss drug Zepbound (tirzepatide) just proven to be more effective than ...
Ibj.com1d
Lilly CEO predicts obesity-treatment Zepbound will become drugmaker’s top drug by 2025
David Ricks told a lunch audience at the Economic Club of Washington, D.C., that Zepbound could quickly become the most ...
Yahoo Finance5d
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Eli Lilly (NYSE: LLY ... of two drugs that have been prescribed for a billion-dollar indication: weight loss. Lilly makes tirzepatide, which is approved for type 2 diabetes under the name Mounjaro ...
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...
MedPage Today6d
Should Pharmaceutical Companies Sell Weight-Loss Drugs Directly to Consumers?
Just a few months after Eli Lilly's tirzepatide (Zepbound ... Pfizer -- which is developing a once-daily weight-loss pill -- followed this summer with PfizerForAll, a digital health platform ...